Since BRD4 knockdown showed a growth-suppressive effect in GC cells alone or in combination with dasatinib, we speculated that molibresib could also suppress the proliferation of GC cells and may showed synergistic effect with dasatinib. The gene discussed is BRD4; the disease is gastric cancer.